Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-10-02
2007-10-02
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S318000, C514S340000, C546S208000, C546S257000
Reexamination Certificate
active
10473087
ABSTRACT:
Aminopyridine derivatives of the following formula I which exhibit pharmacological activity at estrogen receptors alpha (ERα) and beta (ERβ) are described herein. The described invention also includes compositions and medicaments containing the aminopyridine derivatives as well as processes for the preparation and use of such compounds, compositions and medicaments.
REFERENCES:
patent: 99/32447 (1999-07-01), None
patent: 02/22601 (2002-03-01), None
Katritsky, et al “Synthesis of 2-alkylamino- and 2-dialkylamino-4,6-diarylpyridines and 2,4,6-trisubstituted pyrimidines using solid-phase bound chalcones,” J. Comb. Chem, 2000, vol. 2, No. 2, pp. 182-185.
Katritsky et al, “Benzotriazole-assisted preparations of 2-(sunstituted amino) pyridines and pyrid-2-ones,” J. Org. Chem, 1997, vol. 62, No. 18, pp. 6210-6214.
CAPLUS Accession No. 1991:429240, abstract of Shaihla, V et al, “Synthesis and antibacterial activity of some new fluorinated pyrido[2,3-d] pyrimidine derivatives,” Ind. J. Pharm. Sciences, 1990, vol. 52, No. 1, pp. 13-15.
Katritzki, A.R. et al., “Synthese of 2-alkylamino-and 2-dialkylamino-4,6-diarylpyridines and 2,4,6-trisubstituted Pyrimidines Using Solid-Phase Bound Chalcones,”Journal of Combinatorial Chemistry, vol. 2, No. 2, Feb. 26, 2000, pp. 182-185.
Henke, B.R., et al., “2-Amino-4,6-Diarylpyridines as Novel Ligands for the Estrogen Receptor,”Bioorganic&Medicinal Chemistry Letters, vol. 11, No. 14, 2001, pp. 1939-1942.
Katritzky. “Benzotriazole-assisted preparations of 2-(substituted amino)pyridines and pyrid-2-ones,”J. Org. Chem., vol. 62, No. 18, 1997, pp. 6210-6214.
Chemical Abstracts, vol. 115, No. 3, 1991, Abstract No. 29072d, p. 749.
Zecher; Kroehnke,Chem. Ber., vol. 94, 1961, pp. 698-704.
Chemical Abstracts, vol. 100, No. 25, 1984, Abstract No. 209593y, p. 575.
Sammour, et al.,J. Chem. U.A.R., vol. 14, 1971, pp. 581-593.
Sammour, et al.,J. Chem. U.A.R., vol. 13, 1970, pp. 421-431.
Drewry David Harold
Henke Brad Richard
Coppins Janet L.
Coulter Kathryn L.
Lemanowicz John L.
Saeed Kamal A.
SmithKline Beecham Corporation
LandOfFree
Aminopyridine derivatives as estrogen receptor modulators does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aminopyridine derivatives as estrogen receptor modulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aminopyridine derivatives as estrogen receptor modulators will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3840025